What is Superdisintegrants Market?
In recent decades, a variety of pharmaceutical research has been conducted to develop new dosage forms. Among the dosage forms developed to facilitate ease of medication, the rapidly disintegrating tablet (RDT) is one of the most widely employed commercial products. Superdisintegrants are used in tablets and capsules to ensure the rapid break down into their primary particles, facilitating the dissolution or release of the active ingredients and has a versatile range of standard disintegration excipients. The patient's group such as elderly, children, and patients mentally retarded, uncooperative, nauseated, or on reduced liquid intake diets have difficulty in swallowing tablet dosage forms, for rapidly disintegrating tablet, selection of super disintegrants is of prime importance.
The market study is being classified by Type (Modified Starch, Modified Cellulose, Crospovidone and Ion Exchange Resin), by Application (Oncology, Neurology, Cardiology and Infectious Diseases) and major geographies with country level break-up.
BASF SE (Germany), Ashland Global Holdings Inc. (United States), DowDuPont (United States), Roquette Freres (France), DFE Pharma (Germany), JRS PHARMA (Germany), Asahi Kasei Corporation (Japan), Merck KGaA (Germany), Corel Pharma Chem (India) and Avantor Performance Materials (United States) are some of the key players profiled in the study.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Superdisintegrants market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Superdisintegrants market by Type, Application and Region.
On the basis of geography, the market of Superdisintegrants has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Choice of Orally Disintegrating Tablets
- Increasing healthcare expenditure and awareness
- The evolution of New Superdisintegrants for the Pharmaceutical Industry
- The high cost associated with the manufacturing of super disintegrants
- The increasing number of pediatric patients and the geriatric population cannot swallow solid forms of medication and use of Superdisintegrants to overcome this issue and these are significantly used in the manufacturing of disintegrating oral formulations
- Pharmaceutical Market Expansion in Emerging Countries
- Safety and Quality Concerns
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Superdisintegrants Manufacturer, Government Regulatory and Research Organizations and End-Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase